IsoRay Inc. presented "striking" results of its Cesium-131 internal radiation brain cancer therapy and its stock was soaring in early Monday trading.
Richland-based IsoRay (NYSE: ISR), which makes radioactive seeds to treat cancers, said the results of a study conducted by researchers at Barrow Neurological Institute, of the 27 patients in the study, 26 "had not experienced a recurrence of the treated cancer within the treated bed during the follow-up period."
Help employers find you! Check out all the jobs and post your resume.
Richland-based IsoRay (NYSE: ISR), which makes radioactive seeds to treat cancers, said the results of a study conducted by researchers at Barrow Neurological Institute, of the 27 patients in the study, 26 "had not experienced a recurrence of the treated cancer within the treated bed during the follow-up period."
Help employers find you! Check out all the jobs and post your resume.
